Lipid metabolites in the pathogenesis and treatment of neovascular eye disease

Lipids and lipid metabolites have long been known to play biological roles that go beyond energy storage and membrane structure. In age-related macular degeneration and diabetes, for example, dysregulation of lipid metabolism is closely associated with disease onset and progression. At the same time, some lipids and their metabolites can exert beneficial effects in the same disorders. This review summarises our current knowledge of the contributions of lipids to both the pathogenesis and treatment of neovascular eye disease. The clinical entities covered are exudative age-related macular degeneration, diabetic retinopathy and retinopathy of prematurity, with a special emphasis on the potential therapeutic effects of ω3- (also known as n-3) polyunsaturated fatty acids.

[1]  A. Newton,et al.  PHLPP-1 Negatively Regulates Akt Activity and Survival in the Heart , 2010, Circulation research.

[2]  Walter T Ambrosius,et al.  Effects of medical therapies on retinopathy progression in type 2 diabetes. , 2010, The New England journal of medicine.

[3]  Lois E. H. Smith,et al.  Short Communication: PPAR&ggr; Mediates a Direct Antiangiogenic Effect of &ohgr;3-PUFAs in Proliferative Retinopathy , 2010, Circulation research.

[4]  Jing Chen,et al.  The mouse retina as an angiogenesis model. , 2010, Investigative ophthalmology & visual science.

[5]  J. Burgess,et al.  The role of vitamin E and oxidative stress in diabetes complications , 2010, Mechanisms of Ageing and Development.

[6]  I. Fleming,et al.  Epoxyeicosatrienoic acids and endothelium-dependent responses , 2010, Pflügers Archiv - European Journal of Physiology.

[7]  William C. Gordon,et al.  Neuroprotectin D1 Attenuates Laser-induced Choroidal Neovascularization in Mouse , 2010, Molecular vision.

[8]  L. Aiello,et al.  PRELIMINARY ASSESSMENT OF CELECOXIB AND MICRODIODE PULSE LASER TREATMENT OF DIABETIC MACULAR EDEMA , 2010, Retina.

[9]  J. Kopitz,et al.  Effects of lipid peroxidation products on lipofuscinogenesis and autophagy in human retinal pigment epithelial cells. , 2010, Experimental eye research.

[10]  J. Penn,et al.  Role of cytosolic phospholipase A(2) in retinal neovascularization. , 2010, Investigative ophthalmology & visual science.

[11]  J. Kopitz,et al.  Lipid peroxidation products reduce lysosomal protease activities in human retinal pigment epithelial cells via two different mechanisms of action. , 2010, Experimental eye research.

[12]  Elizabeth J Johnson.  Age-related macular degeneration and antioxidant vitamins: recent findings , 2010, Current opinion in clinical nutrition and metabolic care.

[13]  J. Buring,et al.  Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. , 2009, Ophthalmology.

[14]  E. Agrón,et al.  {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study. , 2009, The American journal of clinical nutrition.

[15]  Andreas Stahl,et al.  Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis , 2009, Nature Protocols.

[16]  R. Dana,et al.  Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. , 2009, Investigative ophthalmology & visual science.

[17]  M. Bartoli,et al.  HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy. , 2009, Investigative ophthalmology & visual science.

[18]  A. Stahl,et al.  Computer-aided quantification of retinal neovascularization , 2009, Angiogenesis.

[19]  Hau D. Le,et al.  Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. , 2009, JPEN. Journal of parenteral and enteral nutrition.

[20]  R. J. Ross,et al.  A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration. , 2009, The American journal of pathology.

[21]  A. Lapillonne,et al.  Reevaluation of the DHA requirement for the premature infant. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[22]  Hau D. Le,et al.  The essentiality of arachidonic acid and docosahexaenoic acid. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[23]  Marcus H. Jones.  Effect of preterm birth on airway function and lung growth. , 2009, Paediatric respiratory reviews.

[24]  P. Mitchell,et al.  Dietary fatty acids and the 10-year incidence of age-related macular degeneration: the Blue Mountains Eye Study. , 2009, Archives of ophthalmology.

[25]  J. Uddin,et al.  Selective Survival Rescue in 15-Lipoxygenase-1-deficient Retinal Pigment Epithelial Cells by the Novel Docosahexaenoic Acid-derived Mediator, Neuroprotectin D1* , 2009, The Journal of Biological Chemistry.

[26]  M. Schwartzman,et al.  Profile of Lipid and Protein Autacoids in Diabetic Vitreous Correlates With the Progression of Diabetic Retinopathy , 2009, Diabetes.

[27]  P. Ng,et al.  Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid. , 2009, Clinical nutrition.

[28]  H. Agostini,et al.  Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

[29]  C. Sorenson,et al.  CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression. , 2009, Blood.

[30]  Chiung-Nien Chen,et al.  Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms. , 2008, Cellular signalling.

[31]  Lucy Q. Shen,et al.  Rosiglitazone and delayed onset of proliferative diabetic retinopathy. , 2008, Archives of ophthalmology.

[32]  Charles N. Serhan,et al.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.

[33]  M. Murray,et al.  Modulation of angiogenesis by omega-3 polyunsaturated fatty acids is mediated by cyclooxygenases. , 2008, Blood.

[34]  Joe G Hollyfield,et al.  Oxidative damage–induced inflammation initiates age-related macular degeneration , 2008, Nature Medicine.

[35]  A. Nègre-Salvayre,et al.  Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors , 2008, British journal of pharmacology.

[36]  P. Mitchell,et al.  Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial , 2007, The Lancet.

[37]  B. Klein,et al.  Overview of epidemiologic studies of diabetic retinopathy. , 2007, Ophthalmic epidemiology.

[38]  Lois E. H. Smith,et al.  Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis , 2007, Nature Medicine.

[39]  F. Ferris,et al.  The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. , 2007, Archives of ophthalmology.

[40]  Z. Yildirim,et al.  The Importance of Serum Lipids in Exudative Diabetic Macular Edema in Type 2 Diabetic Patients , 2007, Annals of the New York Academy of Sciences.

[41]  J. Kopitz,et al.  Effects of lipid peroxidation-related protein modifications on RPE lysosomal functions and POS phagocytosis. , 2007, Investigative ophthalmology & visual science.

[42]  B. Weinberger,et al.  Lipid peroxidation in cord blood and neonatal outcome , 2006, Pediatrics international : official journal of the Japan Pediatric Society.

[43]  J. Sears,et al.  Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration , 2006, Proceedings of the National Academy of Sciences.

[44]  D. Ferrington,et al.  Retinal proteins modified by 4-hydroxynonenal: identification of molecular targets. , 2006, Experimental eye research.

[45]  M. Leduc,et al.  [Hypercapnia- and trans-arachidonic acid-induced retinal microvascular degeneration: implications in the genesis of retinopathy of prematurity]. , 2006, Medecine sciences : M/S.

[46]  S. Germain,et al.  Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1–dependent microvascular degeneration , 2005, Nature Medicine.

[47]  M. Tanito,et al.  Protein modifications by 4-hydroxynonenal and 4-hydroxyhexenal in light-exposed rat retina. , 2005, Investigative ophthalmology & visual science.

[48]  J. Sangiovanni,et al.  The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina , 2005, Progress in Retinal and Eye Research.

[49]  J. Kopitz,et al.  Lipids and lipid peroxidation products in the pathogenesis of age-related macular degeneration. , 2004, Biochimie.

[50]  A. Jenkins,et al.  Lipoproteins and diabetic microvascular complications. , 2004, Current pharmaceutical design.

[51]  F. Holz,et al.  Keypathophysiologic pathways in age-related macular disease , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[52]  Marco A Zarbin,et al.  Current concepts in the pathogenesis of age-related macular degeneration. , 2004, Archives of ophthalmology.

[53]  R. Klein,et al.  Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.

[54]  D. Lackland,et al.  Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. , 2004, Investigative ophthalmology & visual science.

[55]  J. Phillis,et al.  A potentially critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disorders , 2004, Brain Research Reviews.

[56]  M. Miyagi,et al.  Carboxyethylpyrrole Protein Adducts and Autoantibodies, Biomarkers for Age-related Macular Degeneration* , 2003, Journal of Biological Chemistry.

[57]  J. Kopitz,et al.  Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium. , 2003, Investigative ophthalmology & visual science.

[58]  Y. Courtois,et al.  Cyclooxygenase-2 in Human and Experimental Ischemic Proliferative Retinopathy , 2003, Circulation.

[59]  R. Busse,et al.  Cytochrome P450 2C9‐derived epoxyeicosatrienoic acids induce angiogenesis via cross‐talk with the epidermal growth factor receptor , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  G. Rao,et al.  5(S)-Hydroxyeicosatetraenoic Acid Stimulates DNA Synthesis in Human Microvascular Endothelial Cells via Activation of Jak/STAT and Phosphatidylinositol 3-Kinase/Akt Signaling, Leading to Induction of Expression of Basic Fibroblast Growth Factor 2* , 2002, The Journal of Biological Chemistry.

[61]  Masaru Miyagi,et al.  Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[62]  C. Serhan,et al.  Resolvins , 2002, The Journal of experimental medicine.

[63]  G. Almazan,et al.  Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy. , 2001, Journal of applied physiology.

[64]  R. Hardy,et al.  The multicenter study of Early Treatment for Retinopathy of Prematurity (ETROP). , 2001, Ophthalmology.

[65]  M. Kesavulu,et al.  Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. , 2000, Diabetes & metabolism.

[66]  M. Boulton,et al.  The role of oxidative stress in the pathogenesis of age-related macular degeneration. , 2000, Survey of ophthalmology.

[67]  T. Inder,et al.  Protein Carbonyls and Lipid Peroxidation Products as Oxidation Markers in Preterm Infant Plasma: Associations with Chronic Lung Disease and Retinopathy and Effects of Selenium Supplementation , 2000, Pediatric Research.

[68]  Dean P. Jones,et al.  Oxidative damage and protection of the RPE , 2000, Progress in Retinal and Eye Research.

[69]  M. Pinazo-Durán,et al.  Lipid peroxidation in proliferative vitreoretinopathies , 1999, Eye.

[70]  J. Gidday,et al.  Mechanisms of hyperoxia-induced reductions in retinal blood flow in newborn pig. , 1998, Experimental eye research.

[71]  W. Wahli,et al.  Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. , 1997, Molecular endocrinology.

[72]  B. Hoogwerf,et al.  Serum Lipids and Diabetic Retinopathy , 1996, Diabetes Care.

[73]  B. Hoogwerf,et al.  Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. , 1996, Archives of ophthalmology.

[74]  J. Bonventre.  Roles of phospholipases A2 in brain cell and tissue injury associated with ischemia and excitotoxicity. , 1996, Journal of Lipid Mediators and Cell Signalling.

[75]  K. Kogure,et al.  Role of platelet-activating factor and thromboxane A2 in radical production during ischemia and reperfusion of the rat brain , 1996, Brain Research.

[76]  L. Aiello,et al.  Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[77]  T. Yaksh,et al.  Time Course of Release in vivo of PGE2, PGF2α, 6-Keto-PGF1α, and TxB2 into the Brain Extracellular Space after 15 Min of Complete Global Ischemia in the Presence and Absence of Cyclooxygenase Inhibition , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[78]  R. Flower,et al.  Prostaglandins as mediators of vasotonia in the immature retina. , 1984, Pediatrics.

[79]  S. Brem,et al.  Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. , 1977, Science.

[80]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[81]  N. Bazan,et al.  Neuroprotectin D1 modulates the induction of pro-inflammatory signaling and promotes retinal pigment epithelial cell survival during oxidative stress. , 2010, Advances in experimental medicine and biology.

[82]  A. Adler,et al.  Micronutrients and diabetic retinopathy a systematic review. , 2010, Ophthalmology.

[83]  J. Kopitz,et al.  Apical-to-basolateral transcytosis of photoreceptor outer segments induced by lipid peroxidation products in human retinal pigment epithelial cells. , 2010, Investigative ophthalmology & visual science.

[84]  P. D. de Jong.  Aspirin and age-related macular degeneration. , 2010, Ophthalmology.

[85]  M. Leduc,et al.  Hypercapnia- and trans-arachidonic acid-induced retinal microvascular degeneration: implications in the genesis of retinopathy of prematurity. , 2006, Seminars in perinatology.

[86]  P. Hardy,et al.  Inflammatory lipid mediators in ischemic retinopathy. , 2005, Pharmacological reports : PR.

[87]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[88]  Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. , 2000, Ophthalmology.

[89]  R. Browne,et al.  Characterization of peroxidized lipids in Bruch's membrane. , 1999, Retina.

[90]  A. Filouš,et al.  [Retinopathy of prematurity]. , 1998, Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti.

[91]  B. Hoogwerf,et al.  Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group. , 1996, Diabetes care.

[92]  Lois E. H. Smith,et al.  Oxygen-induced retinopathy in the mouse. , 1994, Investigative ophthalmology & visual science.

[93]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[94]  Photocoagulation therapy for diabetic eye disease. Early Treatment Diabetic Retinopathy Study Research Group. , 1985, JAMA.

[95]  N. Bazan.  Free arachidonic acid and other lipids in the nervous system during early ischemia and after electroshock. , 1976, Advances in experimental medicine and biology.